Gualtieri C T, Golden R N, Fahs J J
J Dev Behav Pediatr. 1983 Sep;4(3):202-9. doi: 10.1097/00004703-198309000-00010.
This is a report on recent developments in pediatric psychopharmacology: new drugs and new applications for established drugs. The drugs reviewed include imipramine, amitryptiline, lithium, piracetam, propranolol, tryptophan, clonidine, pyridoxine and fenfluramine. Putative indications include prepubertal depression, school phobia, anorexia nervosa, explosive-aggressive behavior, learning disabilities, attention deficit disorder (hyperactivity), Tourette's syndrome, autism, and the Lesch-Nyhan syndrome. Some of the information presented in this report must be regarded as "preliminary," and caution is advised in its interpretation and application.
新药以及现有药物的新应用。所综述的药物包括丙咪嗪、阿米替林、锂盐、吡拉西坦、普萘洛尔、色氨酸、可乐定、吡哆醇和芬氟拉明。假定的适应症包括青春期前抑郁症、学校恐惧症、神经性厌食症、爆发性攻击行为、学习障碍、注意力缺陷障碍（多动症）、妥瑞氏综合征、自闭症以及莱施-奈恩综合征。本报告中呈现的一些信息必须被视为“初步的”，在对其进行解读和应用时建议谨慎。
